You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 129 No. 2, February 1994 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Papers
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (98)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Detrimental Hemodynamic Effects of Nitric Oxide Synthase Inhibition in Septic Shock

Frank M. Robertson, MD; Patrick J. Offner, MD, MPH; David P. Ciceri, MD; William K. Becker, MD; Basil A. Pruitt, Jr, MD

Arch Surg. 1994;129(2):149-156.


Abstract



Objective
To investigate the physiologic effects of nitric oxide synthase inhibition with N-nitro-L-arginine methyl ester in an acute resuscitated model of porcine septic shock.

Design
Randomized control trial.

Setting
Animal research facility.

Study Subjects
Domestic Yorkshire swine.

Interventions
Twenty-four animals were randomly divided into one of four treatment groups as follows: normal saline resuscitation (NSR) (control group); NSR plus 200 µg/kg of lipopolysaccharide (LPS) at 1 hour after baseline (LPS group); NSR, LPS, and a continuous infusion of 50 µg/kg per minute of N-nitro-L-arginine methyl ester (NAME) at 1 hour after baseline (LPS/NAME group); and NSR and NAME (NAME group). All animals received NSR at 1 mL/kg per minute starting at baseline.

Main Outcome Measures
Mean arterial pressure (MAP), systemic vascular resistance index (SVRI), mean pulmonary arterial pressure (MPAP), and pulmonary vascular resistance index (PVRI) were measured at baseline and hourly for 4 hours. Values at baseline and 3 hours are given below as mean (±SE).

Results
All variables remained unchanged in the control group. The administration of LPS produced a systemic hyperdynamic response characterized by a decrease in MAP and SVRI from 66.0±3.9 to 55.0±2.8 mm Hg (P<.05) and from 422.0±22.0 to 272.0±29.0 mm Hg.min.kg/L (P<.05), respectively. The administration of LPS produced an increase in MPAP and PVRI from 16.3±0.8 to 30.0±1.3 mm Hg (P<.05) and from 37.0±5.3 to 119.0±13.0 mm Hg.min.kg/L (P<.05), respectively. In the LPS/NAME group, NAME infusion normalized MAP and increased SVRI from 506.0±40.0 to 642.0±72.0 mm Hg.min.kg/L (P<.05). Infusion of NAME potentiated LPS-induced pulmonary hypertension, increasing MPAP and PVRI from 16.8±0.6 to 36.0±2.8 mm Hg (P<.05) and from 59.0±3.5 to 319.0±64.0 mm Hg.min.kg/L (P<.05), respectively. Infusion of NAME alone increased MAP from 74.0±1.3 to 100.0±4.1 mm Hg (P<.05) and had no significant effect on MPAP and PVRI.

Conclusions
The potentiation of LPS-induced pulmonary hypertension following NAME infusion suggests that inhibition of nitric oxide synthase may have a limited role in the treatment of septic shock.

(Arch Surg. 1994;129:149-156)



Author Affiliations



From the Department of Surgery, Critical Care Service, Brooke Army Medical Center (Drs Robertson, Offner, and Ciceri) and the US Army Institute of Surgical Research (Drs Becker and Pruitt), Fort Sam Houston, Tex.; Dr Robertson is now with the Division of Pediatric Surgery, New England Medical Center, Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antagonism of Lipopolysaccharide-Induced Blood Pressure Attenuation and Vascular Contractility
Ehrentraut et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:2170-2176.
ABSTRACT | FULL TEXT  

Arginine Supplementation and Wound Healing
Stechmiller et al.
Nutr Clin Pract 2005;20:52-61.
ABSTRACT | FULL TEXT  

Modulation of endotoxin-induced cardiopulmonary dysfunction by S-nitroso-albumin
Gluckman et al.
Innate Immunity 2002;8:17-26.
ABSTRACT  

Immunomodulation of Pneumococcal Pulmonary Infection with NG-Monomethyl-L-Arginine
Bergeron et al.
Antimicrob. Agents Chemother. 1999;43:2283-2290.
ABSTRACT | FULL TEXT  

Biphasic changes in left ventricular function during hyperdynamic endotoxemia
Ishihara et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 1999;276:R1516-R1524.
ABSTRACT | FULL TEXT  

Inhaled nitric oxide prevents left ventricular impairment during endotoxemia
Ishihara et al.
J. Appl. Physiol. 1998;85:2018-2024.
ABSTRACT | FULL TEXT  

Microvascular Endothelial Cell Control of Peripheral Vascular Resistance During Sepsis
Tucker et al.
Arch Surg 1998;133:1335-1342.
ABSTRACT | FULL TEXT  

Nitric Oxide Opposes Phorbol Ester-Induced Increases in Pulmonary Microvascular Permeability in Dogs
Sprague et al.
J. Pharmacol. Exp. Ther. 1998;284:443-448.
ABSTRACT | FULL TEXT  

Nitric Oxide Synthase Inhibition Restores Hypoxic Pulmonary Vasoconstriction in Sepsis
FISCHER et al.
Am. J. Respir. Crit. Care Med. 1997;156:833-839.
ABSTRACT | FULL TEXT  

Selective iNOS Inhibition Is Superior to Norepinephrine in the Treatment of Rat Endotoxic Shock
ROSSELET et al.
Am. J. Respir. Crit. Care Med. 1997;157:162-170.
ABSTRACT | FULL TEXT  

Inhaled Nitric Oxide Prevents Experimental Platelet Activating Factor--Induced Shock
Emil et al.
Arch Surg 1996;131:855-860.
ABSTRACT  

Effects of Nitric Oxide Donor SIN-1 on Oxygen Availability and Regional Blood Flow During Endotoxic Shock
Zhang et al.
Arch Surg 1996;131:767-774.
ABSTRACT  

Nitric Oxide and Septic Shock
Cobb and Danner
JAMA 1996;275:1192-1196.
ABSTRACT  

Nitric oxide contributes to desipramine- induced hypotension in rats
Pentel et al.
Hum Exp Toxicol 1996;15:320-328.
ABSTRACT  

Review: Nitric Oxide, Sepsis, and Arginine Metabolism
Kelly et al.
JPEN J Parenter Enteral Nutr 1995;19:234-238.
ABSTRACT  

Detrimental Effects of a Nitric Oxide Synthase Inhibitor (N-{omega}-Nitro-L-Arginine-Methyl-Ester) in a Murine Sepsis Model
Fukatsu et al.
Arch Surg 1995;130:410-414.
ABSTRACT  

The Pulmonary Effect of Nitric Oxide Synthase Inhibition Following Endotoxemia in a Swine Model
Ogura et al.
Arch Surg 1994;129:1233-1239.
ABSTRACT  

The Effects of Nitric Oxide Inhibition on Regional Hemodynamics During Hyperdynamic Endotoxemia
Henderson et al.
Arch Surg 1994;129:1271-1275.
ABSTRACT  

Nitric Oxide: To Block or Enhance Its Production During Sepsis?
Wang et al.
Arch Surg 1994;129:1137-1143.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.